Testing SGC001 for anterior wall heart attack
Part of Heart & circulation clinical trials.
This study tests an investigational drug called SGC001 for people having a heart attack affecting the front wall of the heart. The goal is to see if adding this drug to the standard artery-opening procedure helps improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 79 years old.
- You are having a specific type of heart attack called anterior ST-elevation myocardial infarction (STEMI), with chest pain lasting more than 30 minutes and certain ECG changes.
- You are scheduled to have a procedure (primary PCI) to open the blocked artery.
- You can receive the study drug within 6 hours of when your chest pain started.
- You do not have any of the excluded heart conditions, such as a previous heart attack, prior heart procedures, certain heart rhythm problems, or severe heart failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adding a special heart “reset” step (ischemic postconditioning) and using an imaging guide during the emergency procedure can improve outcomes for people having a STEMI heart attack. It’s meant to optimize treatment when a blocked heart artery is being opened.
This study tests an investigational medicine called MT1002 in people who have had a heart attack and are about to get a stent (PCI). The goal is to see if MT1002 helps prevent further heart problems.
This trial tests treatments for small blood vessel damage after a major heart attack (STEMI). If you have had a heart attack and are receiving a stent, this study may help improve recovery by targeting microvascular injury.
This trial tests whether using a special device to remove blood clots during emergency heart artery opening can improve outcomes for people having a major heart attack on the front of the heart. It is for patients who get to the hospital quickly after symptoms start.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
This study tests a new magnetic heart scan (MCG) to see if it can better detect blocked arteries causing chest pain or heart attacks. It may help doctors decide the best treatment for you.
Hear when a new Acute Anterior ST-Segment Elevation Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.